Kura Oncologyincis A Clinical Stage Biopharmaceutical Company Based In San Diegocaliforniafounded In 2014Kura Focuses On Developing Precision Medicines Aimed At Treating Cancerthe Company Is Dedicated To Creating Targeted Therapies That Help Patients Achieve Long Lasting Remissionparticularly For Those With High Unmet Medical Needs Kura S Product Pipeline Includes Several Innovative Therapiestipifarnib Is In Development For Various Cancersincluding Hras Mutant Head And Neck Cancer And Peripheral T Cell Lymphomasziftomenib Targets Acute Myeloid Leukemia With Specific Genetic Mutationsother Candidates Include Ko 2806A Next Generation Farnesyl Transferase Inhibitorko 539A Small Molecule Inhibitor For Acute Leukemiaand Ko 947Which Targets The Mapk Pathway In Solid Tumorskura Employs A Precision Medicine Strategyutilizing Biomarker Driven Clinical Trials To Identify Patient Subgroups That Are Most Likely To Benefit From Their Treatments
No conferences found for this company.
| Company Name | Kura Oncology Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
